Form 8-K - Current report:
SEC Accession No. 0001628280-24-048173
Filing Date
2024-11-18
Accepted
2024-11-18 07:20:09
Documents
15
Period of Report
2024-11-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K twist-20241118.htm   iXBRL 8-K 29480
2 EX-99.1 twst-20240930xex991.htm EX-99 155037
6 image_2.jpg GRAPHIC 23636
  Complete submission text file 0001628280-24-048173.txt   355689

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT twist-20241118.xsd EX-101.SCH 1825
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT twist-20241118_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT twist-20241118_pre.xml EX-101.PRE 12539
17 EXTRACTED XBRL INSTANCE DOCUMENT twist-20241118_htm.xml XML 2811
Mailing Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 681 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 800-719-0671
Twist Bioscience Corp (Filer) CIK: 0001581280 (see all company filings)

EIN.: 462058888 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38720 | Film No.: 241469758
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)